High-dose cerium dioxide nanorods induce behavioral and electroencephalographic abnormalities through 5-HT1B receptor signaling disruption with an evaluation of anpirtoline's therapeutic potential.
Liu M, Li Y, Shen C, Huang H, Liu Q, Fu B, Wu B, Wu X, Luo Y, Shan Y, Niu X, Zhao G
The online reader was unable to display this document directly. This may occur if the repository host is temporarily unreachable, or if security restrictions (CORS) prevent embedded viewing.